Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1994 | 12-1993 | 12-1992 | 12-1991 | 12-1990 | |
| Sales | 4,715 | 2,918 | 2,534 | 1,644 | 1,045 |
| Cost of Goods | 3,718 | 2,859 | 2,577 | 1,912 | 1,518 |
| Gross Profit | 997 | 60 | -43 | -268 | -473 |
| Operating Expenses | 3,185 | 2,383 | 1,681 | 2,127 | 1,799 |
| Operating Income | -1,470 | -1,465 | -1,147 | -1,483 | -1,755 |
| Interest Expense | 28 | 63 | 73 | 18 | 0 |
| Other Income | 656 | -698 | -347 | -93 | -617 |
| Pre-tax Income | -842 | -2,226 | -1,566 | -1,594 | -2,371 |
| Income Tax | 22 | 2 | -60 | 19 | 15 |
| Net Income Continuous | -840 | -1,897 | -1,167 | -1,296 | -2,112 |
| Net Income Discontinuous | 222 | -9 | 181 | 0 | -491 |
| Net Income | $-618 | $-1,906 | $-987 | $-1,296 | $-2,603 |
| EPS Basic Total Ops | -0.11 | -0.36 | -0.19 | -0.26 | -0.54 |
| EPS Basic Continuous Ops | -0.15 | -0.33 | -0.22 | -0.25 | -0.44 |
| EPS Basic Discontinuous Ops | 0.04 | 0.00 | 0.03 | N/A | -0.10 |
| EPS Diluted Total Ops | -0.11 | -0.36 | -0.19 | -0.25 | -0.54 |
| EPS Diluted Continuous Ops | -0.15 | -0.33 | -0.22 | -0.25 | -0.44 |
| EPS Diluted Discontinuous Ops | 0.04 | 0.00 | 0.03 | N/A | -0.10 |
| EBITDA(a) | $-1,470 | $-1,041 | $-828 | $-1,307 | $-1,632 |